Email Updates

You are here

18 JUNE 2021 VOLUME 23 ISSUE 24

Media Coverage

  • As Congress continues its attention to pharmaceutical development and prices, the US Senate Committee on Finance’s Subcommittee on Fiscal Responsibility and Economic Growth has called for a hearing entitled “Promoting Domestic Competition and International Competitiveness.” The Subcommittee has invited Gilead Sciences CEO, Daniel O’Day to testify about the current state of competition in the pharmaceutical industry and the impact of Gilead’s pricing decisions on access.

    June 16, 2021
    Health Affairs
  • Since his son was diagnosed with HIV during a mass outbreak among babies and children in Pakistan, Shahzado Shar has often been forced to choose between food and medicine. His five-year-old was one of the hundreds who tested positive in 2019 after a whistle-blower doctor uncovered a scandal involving the reuse of needles in southern Sindh province.

    June 15, 2021
    Al Jazeera
  • HIV diagnosis among overseas-born gay and bisexual men, especially those who have come to Australia from Asia, has increased from 28 per cent in 2008 to 52 per cent in 2017, according to the Australian Annual Surveillance report. Now, a new video campaign in Mandarin from ACON hopes to reach out to this vulnerable population to raise awareness about HIV prevention drug PrEP.

    June 15, 2021
    Star Observer
  • The Boston Health Care for the Homeless Program more than doubled the number of PrEP prescriptions among people who use drugs who are experiencing homelessness compared to the previous year after adopting an innovative, low-threshold model of care.

    June 15, 2021
  • On Tuesday (June 8), the UN General Assembly voted overwhelmingly to approve the 2021 Political Declaration on HIV and AIDS introduced as part of the now fifth High Level Meeting on HIV/AIDS. Previous Declarations were accepted by unanimous consent, following months of negotiations. This year’s Political Declaration includes much to applaud, including new ambitious targets for prevention, investment goals to ensure everyone who needs treatment has access to it, and a financial and moral commitment to end gender inequality, stigma and discrimination.

    June 14, 2021
    Science Speaks
  • Vaccine development is an important strategy for the prevention of infectious diseases and reducing the morbidity and mortality rates. Researchers have been working on finding an HIV vaccine since the 1980s but the development of an effective vaccine has been slow-moving.

    June 14, 2021
    Health-E News
  • The National Institutes of Health (NIH) is the world’s single largest funder of medical research, the very fuel that feeds the American engine of medical discovery and the linchpin to our country’s post-COVID economic recovery. The Biden administration is proposing to fund the NIH at $52 billion in 2022, a 21 percent increase over the current level. It’s a good start, but not nearly enough.

    June 13, 2021
  • The goal to end AIDS by 2030 could be achievable according to the latest United Nations AIDS (UNAIDS) report, and while many countries have taken great strides to end their HIV epidemics, some countries and entire regions may have stalled their progress.

    June 13, 2021
  • Research in rural Kenya and Uganda has again highlighted the persistence of HIV-related stigma, and the damaging impact it has. In particular, it found women were likely to both hold and be the targets of negative attitudes.

    June 11, 2021
  • Dr. John Carlo is concerned that patients at Prism Health North Texas who rely on the health care safety net will soon be struggling even more to stay on PrEP, a medication that prevents HIV transmission.

    June 11, 2021
    PBS NewsHour
  • With COVID-19 having engulfed the entire globe, HIV prevention, testing, treatment and care services are being disrupted, particularly in countries with fragile health systems. This is a major threat to the gains we’ve made fighting the HIV/AIDS epidemic, because we know that any slowing down of these initiatives will leave many vulnerable populations at greater risk of infection.

    June 10, 2021
    Daily Maverick
  • The rapid and devastating movement of COVID around the world has eclipsed other health priorities over the last 18 months. The emergence of SARS-CoV-2 has overcome fragile health systems, led to the deaths of over 3.7 million people and reversed decades of progress on expanding social protection, education, child protection, and gender equality. In the shadow of this new pandemic, we have also seen some of the hard-won gains against HIV, TB, and malaria begin to unravel—especially in countries where COVID vaccination is scarce.

    June 7, 2021
    Think Global Health

Published Research